Genomic profiling and clinical outcomes with first-line atezolizumab and nab-paclitaxel in triple-negative breast cancer: An exploratory analysis from the phase 3 IMpassion130 trial

Leisha Emens, Luciana Molinero, Sylvia Adams, Hope S Rugo, Andreas Schneeweiss, Veronique Dieras, Hiroji Iwata, Carlos Barrios, Eric P Winer, Ching-Wei Chang, Stephen Y Chui, Peter Schmid, Sherene Loi